|
| Interactions: | Amoxycillin
Adverse Effect: loss of Netilmicin efficacy Clinical Management: Monitor patients for Netilmicin effectiveness.
Amoxycillin + Bromhexine Comb.
Adverse Effect: Loss of aminoglycoside efficacy Clinical Management: Monitor patients for aminoglycoside effectiveness.
Amoxycillin + Carbocisteine Comb.
Adverse Effect: Loss of aminoglycoside efficacy Clinical Management: Monitor patients for aminoglycoside effectiveness.
Amoxycillin + Clavulanic Acid Comb.
Adverse Effect: Loss of aminoglycoside efficacy Clinical Management: Monitor patients for aminoglycoside effectiveness.
Amoxycillin + Cloxacillin Comb
Adverse Effect: Loss of aminoglycoside efficacy Clinical Management: Monitor patients for aminoglycoside effectiveness.
Ampicillin
Adverse Effect: loss of Netilmicin efficacy Clinical Management: Monitor patients for Netilmicin effectiveness.
Atracurium
Adverse Effect: enhanced and/or prolonged neuromuscular blockade which may lead to respiratory depression and paralysis Clinical Management: Avoid concomitant use of Netilmicin and Atracurium if possible. Concurrent use of Netilmicin and Atracurium requires close monitoring of the patients clinical condition, especially respiratory and oxygenation status.
Bacampicillin
Adverse Effect: Loss of Netilmicin efficacy Clinical Management: Monitor patients for Netilmicin effectiveness.
Benzathine Penicillin
Adverse Effect: Loss of Netilmicin efficacy Clinical Management: Monitor patients for Netilmicin effectiveness.
Benzyl Penicillin
Adverse Effect: loss of Netilmicin efficacy Clinical Management: Monitor patients for Netilmicin effectiveness.
Bumetanide
Adverse Effect: Ototoxicity Clinical Management: Consider periodic auditory testing for patients with renal dysfunction, or for patients on high doses of either drug.
Capreomycin
Adverse Effect: Netilmicin toxicity (ototoxicity, nephrotoxicity) Clinical Management: If concomitant administration is necessary, respiratory function, renal function and auditory function should be monitored closely.
Carbenicillin
Adverse Effect: Loss of Netilmicin efficacy Clinical Management: Monitor patients for Netilmicin effectiveness.
Carboplatin
Adverse Effect: ototoxicity Clinical Management: If clinically acceptable, an alternate antibiotic (a non-aminoglycoside) may be preferred.
Cefaclor
Adverse Effect: an increased risk of nephrotoxicity Clinical Management: Coadministration of Netilmicin with Cefaclor could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Cefadroxil
Adverse Effect: an increased risk of nephrotoxicity Clinical Management: Coadministration of Netilmicin with Cefadroxil could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Cefazolin
Adverse Effect: an increased risk of nephrotoxicity Clinical Management: Coadministration of Netilmicin with Cefazolin could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Cefixime
Adverse Effect: an increased risk of nephrotoxicity Clinical Management: Coadministration of Netilmicin with Cefixime could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Cefoperazone
Adverse Effect: an increased risk of nephrotoxicity Clinical Management: Coadministration of Netilmicin with Cefoperazone could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Cefotaxime
Adverse Effect: an increased risk of nephrotoxicity Clinical Management: Coadministration of Netilmicin with Cefotaxime could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Cefpirome
Adverse Effect: an increased risk of nephrotoxicity Clinical Management: Coadministration of Netilmicin with Cefpirome could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Cefpodoxime
Adverse Effect: an increased risk of nephrotoxicity Clinical Management: Coadministration of Netilmicin with Cefpodoxime could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Ceftazidime
Adverse Effect: an increased risk of nephrotoxicity Clinical Management: Coadministration of Netilmicin with Ceftazidime could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Ceftizoxime
Adverse Effect: an increased risk of nephrotoxicity Clinical Management: Coadministration of Netilmicin with Ceftizoxime could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Ceftriaxone
Adverse Effect: an increased risk of nephrotoxicity Clinical Management: Coadministration of Netilmicin with Ceftriaxone could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Cefuroxime
Adverse Effect: an increased risk of nephrotoxicity Clinical Management: Coadministration of Netilmicin with Cefuroxime could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Cephalexin
Adverse Effect: an increased risk of nephrotoxicity Clinical Management: Coadministration of Netilmicin with Cephalexin could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Cephaloridine
Adverse Effect: an increased risk of nephrotoxicity Clinical Management: Coadministration of Netilmicin with Cephaloridine could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Cloxacillin
Adverse Effect: Loss of Netilmicin efficacy Clinical Management: Monitor patients for Netilmicin effectiveness.
Frusemide
Adverse Effect: ototoxicity and/or nephrotoxicity Clinical Management: Consider periodic auditory testing for patients on high doses of either drug. Also monitor renal function.
Mg. salts
Adverse Effect: Neuromuscular weakness Clinical Management: Monitor patients for respiratory dysfunction and apnea. If neuromuscular blockade occurs, discontinue the Netilmicin and change antibiotic therapy. Patients receiving large cumulative doses of Netilmicin should have serum calcium, magnesium, potassium, and creatinine monitored.
Pancuronium
Adverse Effect: enhanced and/or prolonged neuromuscular blockade which may lead to respiratory depression and paralysis Clinical Management: Avoid concomitant use of Netilmicin and Pancuronium if possible. Concurrent use of Netilmicin and Pancuronium requires close monitoring of the patients clinical condition, especially respiratory and oxygenation status.
Penicillin V ( Phenoxymethyl )
Adverse Effect: loss of Netilmicin efficacy Clinical Management: Monitor patients for Netilmicin effectiveness.
Pipecuronium
Adverse Effect: enhanced and/or prolonged neuromuscular blockade which may lead to respiratory depression and paralysis Clinical Management: Avoid concomitant use of Netilmicin and Pipecuronium if possible. Concurrent use of Netilmicin and Pipecuronium requires close monitoring of the patients clinical condition, especially respiratory and oxygenation status.
Piperacillin
Adverse Effect: Loss of Netilmicin efficacy Clinical Management: Monitor patients for Netilmicin effectiveness.
Procaine Penicillin
Adverse Effect: Loss of Netilmicin efficacy Clinical Management: Monitor patients for Netilmicin effectiveness.
Succinyl Choline
Adverse Effect: succinylcholine toxicity (respiratory depression, apnea) Clinical Management: Titrate the dose of the neuromuscular blocking agent carefully. Monitor patients not on a ventilator for respiratory paralysis.
Vecuronium
Adverse Effect: enhanced and/or prolonged neuromuscular blockade which may lead to respiratory depression and paralysis Clinical Management: Avoid concomitant use of Netilmicin and Vecuronium if possible. Concurrent use of Netilmicin and Vecuronium requires close monitoring of the patients clinical condition, especially respiratory and oxygenation status.
|
|
|